Find Coagulation Factor VIII manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Related ProductsRelated Products

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

API REF. PRICE (USD/KG)

$
$ 0

GLOBAL SALES INFORMATION

US Medicaid

NA

Regulatory FDF Prices

NA

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

0

API

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Annual Reports

read-more
read-more

01

Brand Name : NovoEight

Human Coagulation factor VIII

arrow
Bioequity Europe
Not Confirmed

Brand Name : NovoEight

Denmark
arrow
Bioequity Europe
Not Confirmed

Human Coagulation factor VIII

Main Therapeutic Indication : Hematology

Currency : USD

2020 Revenue in Millions : 238

2019 Revenue in Millions : 248

Growth (%) : -4

blank

02

Brand Name : of which Novoeight

Human Coagulation Factor VIII

arrow
Bioequity Europe
Not Confirmed

Brand Name : of which Novoeight

Denmark
arrow
Bioequity Europe
Not Confirmed

Human Coagulation Factor VIII

Main Therapeutic Indication : Blood Disorders

Currency : USD

2018 Revenue in Millions : 203

2017 Revenue in Millions : 165

Growth (%) : 23%

blank

03

Brand Name : NovoEight

Human Coagulation factor VIII

arrow
Bioequity Europe
Not Confirmed

Brand Name : NovoEight

Denmark
arrow
Bioequity Europe
Not Confirmed

Human Coagulation factor VIII

Main Therapeutic Indication : Hematology

Currency : USD

2019 Revenue in Millions : 229

2018 Revenue in Millions : 203

Growth (%) : 13

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Market Place

Do you need sourcing support? Ask us

FDF DOSSIERS

read-more
read-more
PharmaCompass
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty